Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Johnson & Johnson
< Previous
1
2
3
4
Next >
Johnson & Johnson to Acquire Shockwave Medical
April 05, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
SWAV
Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
April 04, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Expands Commitment to Advance Health Equity
April 03, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
April 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 11, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Ambrx
March 07, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
February 14, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
February 12, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference
February 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
January 23, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
January 08, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
January 02, 2024
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
December 11, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 07, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
December 05, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
November 30, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Enterprise Business Review
November 16, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
October 23, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023
October 19, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q3 2023 Results
October 17, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 18, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
September 14, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
August 30, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
August 23, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
KVUE
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 22, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
August 21, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
KVUE
Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.
August 16, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
KVUE
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
August 07, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
July 24, 2023
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2023
July 20, 2023
From
Johnson & Johnson
Via
Business Wire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today